Skip to search formSkip to main contentSkip to account menu

WR279396

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Aminoglycosides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2002
Highly Cited
2002
Treatment of cutaneous leishmaniasis with a topical antileishmanial drug (WR279396): phase 2 pilot study.
We studied the efficacy of WR279396, a topical formulation of aminoglycosides that cures 100% of cutaneous leishmaniasis lesions… 
2002
2002
Topical Treatment of Cutaneous Leishmaniasis with WR279396: A Phase II Study in the Old World
Abstract : Action was taken in three directions: 1) Coordination between sites. The French Study Coordinator visited the Tunisian… 
1995
1995
Four Week Toxicity Study of WR279396 After Daily Dermal Application in CD (registered trademark) Rats
Abstract : This study evaluated the toxicity of WR279396 (Iowa Formulation 232 containing 15% paromomycin sulfate and 0.5… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)